Translocation of Analogues of the Antimicrobial Peptides Magainin and Buforin across Human Cell Membranes*
暂无分享,去创建一个
[1] G. Drin,et al. Translocation of protegrin I through phospholipid membranes: role of peptide folding. , 2002, Biochimica et biophysica acta.
[2] S. Futaki,et al. Possible Existence of Common Internalization Mechanisms among Arginine-rich Peptides* , 2002, The Journal of Biological Chemistry.
[3] M. Zasloff. Antimicrobial peptides of multicellular organisms , 2002, Nature.
[4] K Sandvik,et al. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm , 2001, FEBS letters.
[5] A. Mor,et al. Affinity driven molecular transfer from erythrocyte membrane to target cells , 2001, Peptides.
[6] R. Brasseur,et al. Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. , 2001, Biochemistry.
[7] K. Pattabiraman,et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] B. Nordén,et al. The Antennapedia peptide penetratin translocates across lipid bilayers – the first direct observation , 2000, FEBS letters.
[9] D. Piwnica-Worms,et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.
[10] H. Ginsburg,et al. Antimalarial Activities of Dermaseptin S4 Derivatives , 2000, Antimicrobial Agents and Chemotherapy.
[11] C. B. Park,et al. Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. , 2000, Biochemistry.
[12] K. Matsuzaki. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. , 1999, Biochimica et biophysica acta.
[13] M. Itakura,et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptor-related human ST2 gene in UT-7 and TM12 cells. , 1999, European journal of biochemistry.
[14] D. Dekkers,et al. Lipid translocation across the plasma membrane of mammalian cells. , 1999, Biochimica et biophysica acta.
[15] B. Wiesner,et al. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.
[16] K. Matsuzaki,et al. Magainins as paradigm for the mode of action of pore forming polypeptides. , 1998, Biochimica et biophysica acta.
[17] R. Gallo,et al. PR-39, a Syndecan-inducing Antimicrobial Peptide, Binds and Affects p130Cas * , 1998, The Journal of Biological Chemistry.
[18] C. B. Park,et al. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. , 1998, Biochemical and biophysical research communications.
[19] R. Hancock,et al. Cationic peptides: a new source of antibiotics. , 1998, Trends in biotechnology.
[20] Y. Shai,et al. Selective Cytotoxicity of Dermaseptin S3 toward IntraerythrocyticPlasmodium falciparum and the Underlying Molecular Basis* , 1997, The Journal of Biological Chemistry.
[21] N. Fujii,et al. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. , 1997, Biochimica et biophysica acta.
[22] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[23] N. Fujii,et al. Modulation of magainin 2-lipid bilayer interactions by peptide charge. , 1997, Biochemistry.
[24] N. Fujii,et al. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.
[25] C. B. Park,et al. A novel antimicrobial peptide from Bufo bufo gargarizans. , 1996, Biochemical and biophysical research communications.
[26] B. Haimovich,et al. Magainin-induced cytotoxicity in eukaryotic cells: kinetics, dose-response and channel characteristics. , 1995, Biochimica et biophysica acta.
[27] K. Miyajima,et al. Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. , 1995, Biochemistry.
[28] N. Fujii,et al. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. , 1995, Biochemistry.
[29] N. Fujii,et al. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. , 1995, Biochemistry.
[30] M. Herlyn,et al. Experimental local therapy of human melanoma with lytic magainin peptides , 1995, International journal of cancer.
[31] N. Fujii,et al. Orientational and aggregational states of magainin 2 in phospholipid bilayers. , 1994, Biochemistry.
[32] M. Zasloff,et al. Anticancer efficacy of Magainin2 and analogue peptides. , 1993, Cancer research.
[33] A. Gazdar,et al. Antitumor activity of magainin analogues against human lung cancer cell lines. , 1992, Cancer research.
[34] J. Barker,et al. Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Schmid,et al. ATP is required for receptor-mediated endocytosis in intact cells , 1990, The Journal of cell biology.
[36] H. Westerhoff,et al. Interactions between a new class of eukaryotic antimicrobial agents and isolated rat liver mitochondria. , 1989, Biochimica et biophysica acta.
[37] M. Zasloff,et al. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor , 1987 .
[38] Robert E W Hancock,et al. Role of membranes in the activities of antimicrobial cationic peptides. , 2002, FEMS microbiology letters.
[39] A. Balows. Development of novel antimicrobial agents: emerging strategies: Lohner, K. editor; 270pp, 2001, Horizon Scientific Press, Norfold, U.K. ISBN 1-8 98486-23-9 $135.00 , 2002 .
[40] K. Lohner. Development of novel antimicrobial agents: emerging strategies. , 2001 .
[41] Alessandro Tossi,et al. Amphipathic, α‐helical antimicrobial peptides , 2000 .